Inventor · Marseilles, FR

Pascale Andre

18Patents
7h-index
35Co-inventors
62Inventor score

Filing activity: Dec 27, 2005 → Apr 8, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US8119775B2 Human anti-KIR antibodies Chemistry; Metallurgy 38 Active
US9067997B2 Anti-KIR antibodies for the treatment of inflammatory and autoimmune disorders Emerging Cross-Sectional Technologies 20 Active
US8993319B2 Monoclonal antibodies against NKG2A Physics 16 Active
US10329348B2 Treatment of cancers using anti-NKG2A agents Chemistry; Metallurgy 15 Active
US10160810B2 Monoclonal antibodies against NKG2A Physics 14 Active
US8981065B2 Human anti-KIR antibodies Chemistry; Metallurgy 13 Active
US8637258B2 Compositions and methods for regulating NK cell activity Chemistry; Metallurgy 9 Active
US10711063B2 Neutralization of inhibitory pathways in lymphocytes Chemistry; Metallurgy 7 Active
US10676523B2 Treatment regimens using anti-NKG2A antibodies Chemistry; Metallurgy 7 Active
US10870700B2 Neutralization of inhibitory pathways in lymphocytes Chemistry; Metallurgy 6 Active
US8614307B2 Nucleic acids encoding human anti-kir antibodies Chemistry; Metallurgy 6 Active
US9789182B2 Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer Chemistry; Metallurgy 5 Active
US11225519B2 Treatment of cancers using anti-NKG2A agents Chemistry; Metallurgy 3 Active
US11572410B2 Neutralization of inhibitory pathways in lymphocytes Chemistry; Metallurgy 3 Active
US9844593B2 Methods for treatment of recurrent hematological malignancies Emerging Cross-Sectional Technologies 2 Active
US10494433B2 Combination of anti-KIR and anti-CS1 antibodies to treat multiple myeloma Chemistry; Metallurgy 1 Active
US10688180B2 Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer Chemistry; Metallurgy 1 Active
US12037392B2 Treatment regimens using anti-NKG2A antibodies Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.